Compare ALBT & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALBT | SPRC |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.3M |
| IPO Year | 2015 | 2014 |
| Metric | ALBT | SPRC |
|---|---|---|
| Price | $0.27 | $4.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 579.8K | 35.2K |
| Earning Date | 08-14-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.21 | $0.46 |
| 52 Week High | $4.74 | $15.79 |
| Indicator | ALBT | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 40.51 |
| Support Level | $0.21 | $3.28 |
| Resistance Level | $0.39 | $4.85 |
| Average True Range (ATR) | 0.02 | 0.59 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 55.13 | 33.14 |
Avalon Globocare Corp is a technology driven company with a focus on developing products and services that serve growing consumer health and technology markets. Through its AI-driven subsidiary, the company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Its segments consist of a consumer health technology segment, through which it distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America; and an artificial intelligence content technology segment, through which it develops and commercializes an AI-driven, short-form video generation platform.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.